Investors

Press Releases

NASDAQ: ENVB

Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts

Press Releases

Enveric Biosciences to Participate in the Planet MicroCap Showcase on April 21st

April 14, 2021

Enveric Biosciences Appoints Carter Ward as Chief Financial Officer

April 12, 2021

Enveric Biosciences Reports Full Year 2020 Financial Results and Provides Shareholder Update on its Accomplishments in 2021

April 1, 2021

Enveric Biosciences Appoints Dr. Douglas D. Lind to Company’s Board of Directors

March 18, 2021

Enveric Biosciences to Participate in Upcoming Investor Conferences in March

March 15, 2021

Enveric Biosciences Signs Definitive Agreement to Acquire Exclusive License for Novel Molecules from Diverse Biotech

March 10, 2021

Enveric Biosciences Launches Development Collaboration and Supply Agreement with PureForm Global to Support Cannabinoid Clinical Programs

February 25, 2021

Enveric Biosciences Inc. Announces Closing of $12.8 Million Registered Direct Offering of Common Stock

February 12, 2021

Enveric Biosciences Inc. Announces $12.8 Million Registered Direct Offering

February 9, 2021

Enveric Biosciences Issues Shareholder Letter Providing Strategic Vision for Advancing Novel Prescription Supportive Care Cancer Therapies

January 19, 2021

‹
1
…
12
13
14
15
›

Company

Team

Psybrary™

Pipeline

Investors

Contact

Sign Up for Updates

© 2025 Enveric Biosciences | Terms of Use | Privacy Policy

Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.